You can check out the annual or quarterly balance sheets of Milestone Pharmaceuticals Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

Total equity

Cash, cash equivalents and short-term investments

292.95%170.61M

229.20%184.22M

52.03%105.96M

8.07%82.58M

-47.85%43.42M

-37.46%55.96M

5.59%69.69M

0.89%76.42M

-4.95%83.25M

-11.36%89.48M

2.20%66.00M

-1.93%75.75M

1.57%87.59M

0.71%100.95M

-43.42%64.58M

-38.91%77.23M

-36.49%86.24M

-22.81%100.24M

-19.79%114.14M

22.85%126.43M

58.96%135.79M

27.54%129.86M

18.77%142.31M

-24.61%102.91M

-41.42%85.43M

42.86%101.82M

--119.82M

--136.50M

--145.82M

--71.27M

- Cash and cash equivalents

299.37%169.73M

58.18%71.32M

188.56%73.05M

264.76%46.69M

220.46%42.50M

345.02%45.09M

83.97%25.31M

29.56%12.80M

-59.31%13.26M

-86.30%10.13M

80.20%13.76M

-73.50%9.88M

-48.46%32.59M

-19.83%73.95M

-93.31%7.64M

-66.54%37.29M

-35.34%63.24M

28.36%92.24M

57.85%114.14M

137.53%111.43M

83.05%97.79M

-29.42%71.86M

-39.65%72.31M

-55.95%46.91M

-51.79%53.43M

42.92%101.82M

--119.82M

--106.50M

--110.82M

--71.24M

-Short-term investments

-4.03%881.00K

938.34%112.90M

-25.84%32.91M

-43.57%35.90M

-98.69%918.00K

-86.30%10.87M

-15.05%44.38M

-3.41%63.62M

27.26%69.99M

193.89%79.35M

-8.26%52.24M

64.89%65.87M

139.13%55.00M

237.50%27.00M

--56.95M

166.31%39.95M

-39.47%23.00M

-86.21%8.00M

-100.00%0.00

-73.21%15.00M

18.75%38.00M

--58.00M

--70.00M

86.67%56.00M

-8.57%32.00M

----

--0.00

--30.00M

--35.00M

--29.00K

Receivables

97.75%3.96M

131.42%5.00M

46.72%3.51M

-26.37%1.51M

-16.30%2.00M

1.74%2.16M

-37.91%2.39M

-2.01%2.05M

51.94%2.39M

0.76%2.12M

217.48%3.85M

231.75%2.09M

96.88%1.57M

220.85%2.11M

151.14%1.21M

73.08%630.00K

-30.13%800.00K

-39.89%657.00K

-49.05%483.00K

-63.78%364.00K

35.02%1.15M

15.91%1.09M

13.40%948.00K

5.46%1.00M

22.01%848.00K

78.26%943.00K

--836.00K

--953.00K

--695.00K

--529.00K

-Accounts and notes receivable

--2.72M

--1.60M

----

-Other receivables

-24.94%587.00K

177.09%2.82M

26.47%3.02M

-77.64%458.00K

-22.23%1.86M

-5.32%2.01M

-37.91%2.39M

-2.01%2.05M

51.94%2.39M

0.76%2.12M

217.48%3.85M

231.75%2.09M

96.88%1.57M

220.85%2.11M

151.14%1.21M

73.08%630.00K

-30.13%800.00K

-39.89%657.00K

-49.05%483.00K

-63.78%364.00K

35.02%1.15M

15.91%1.09M

13.40%948.00K

5.46%1.00M

22.01%848.00K

121.36%943.00K

--836.00K

--953.00K

--695.00K

--426.00K

Inventory

--4.72M

--1.83M

--648.00K

----

Prepaid expenses

38.37%1.03M

-48.64%1.21M

-1.90%1.80M

2.14%2.58M

-56.33%748.00K

-0.25%2.36M

-42.10%1.84M

-63.76%2.52M

-68.28%1.71M

-56.64%2.36M

-47.08%3.18M

37.62%6.96M

55.84%5.40M

33.90%5.45M

39.68%6.00M

-15.25%5.06M

-53.47%3.46M

-35.35%4.07M

-20.80%4.30M

70.32%5.97M

21.44%7.45M

302.04%6.29M

194.20%5.43M

-0.37%3.50M

21.86%6.13M

-71.45%1.56M

--1.84M

--3.52M

--5.03M

--5.48M

Other current assets

----

--0.00

--898.00K

--0.00

----

Total current assets

290.59%180.33M

217.90%192.25M

51.40%111.92M

7.01%86.67M

-47.15%46.17M

-35.64%60.48M

1.22%73.93M

-4.49%80.99M

-7.62%87.36M

-13.40%93.97M

1.71%73.03M

2.26%84.80M

4.49%94.57M

3.37%108.51M

-39.62%71.80M

-37.54%82.92M

-37.32%90.50M

-23.52%104.97M

-20.02%118.92M

23.59%132.76M

56.25%144.39M

31.56%137.24M

21.38%148.69M

-23.80%107.42M

-39.03%92.41M

35.00%104.32M

--122.50M

--140.97M

--151.55M

--77.28M

Non-current assets

Net Fixed Assets

3.92%1.30M

5.04%1.48M

4.26%1.64M

-37.06%1.08M

-33.32%1.25M

-30.68%1.41M

-28.30%1.57M

-26.00%1.72M

-23.64%1.87M

-20.92%2.03M

-18.13%2.19M

-18.57%2.32M

207.78%2.45M

208.76%2.57M

189.42%2.68M

179.76%2.85M

-28.13%797.00K

-30.53%833.00K

-28.11%926.00K

-26.12%1.02M

51.30%1.11M

44.11%1.20M

38.64%1.29M

49.62%1.38M

156.29%733.00K

169.26%832.00K

--929.00K

--921.00K

--286.00K

--309.00K

Other non-current assets

----

--0.00

----

Total non-current assets

3.92%1.30M

5.04%1.48M

4.26%1.64M

-37.06%1.08M

-33.32%1.25M

-30.68%1.41M

-28.30%1.57M

-26.00%1.72M

-23.64%1.87M

-20.92%2.03M

-18.13%2.19M

-18.57%2.32M

207.78%2.45M

208.76%2.57M

189.42%2.68M

179.76%2.85M

-28.13%797.00K

-30.53%833.00K

-28.11%926.00K

-26.12%1.02M

51.30%1.11M

44.11%1.20M

38.64%1.29M

49.62%1.38M

156.29%733.00K

169.26%832.00K

--929.00K

--921.00K

--286.00K

--309.00K

Total assets

283.04%181.63M

213.05%193.73M

50.41%113.56M

6.10%87.75M

-46.86%47.42M

-35.54%61.88M

0.36%75.50M

-5.06%82.71M

-8.03%89.23M

-13.57%96.00M

1.00%75.23M

1.57%87.12M

6.27%97.02M

4.99%111.08M

-37.85%74.48M

-35.89%85.77M

-37.25%91.30M

-23.58%105.80M

-20.09%119.85M

22.96%133.78M

56.21%145.50M

31.65%138.44M

21.51%149.97M

-23.32%108.80M

-38.66%93.14M

35.53%105.16M

--123.43M

--141.89M

--151.84M

--77.59M

Liabilities

Current liabilities

-Other payables

--43.00K

--398.00K

--0.00

----

--33.00K

----

Accrued expenses

105.19%11.98M

-2.33%9.80M

35.94%7.64M

125.22%6.86M

79.64%5.84M

443.13%10.04M

108.34%5.62M

-46.85%3.04M

-16.43%3.25M

-59.59%1.85M

-20.17%2.70M

80.04%5.73M

50.78%3.89M

237.74%4.57M

56.02%3.38M

128.43%3.18M

116.99%2.58M

-37.08%1.35M

70.23%2.17M

0.14%1.39M

-54.81%1.19M

-26.90%2.15M

-64.84%1.27M

-73.01%1.39M

-14.02%2.63M

57.77%2.94M

--3.62M

--5.15M

--3.06M

--1.87M

Deferred liabilities

--1.03M

--416.00K

----

Other current liabilities

--1.08M

--459.00K

--43.00K

--398.00K

--0.00

----

--33.00K

----

Total current liabilities

138.97%22.18M

61.57%20.94M

72.03%13.98M

100.15%10.52M

103.26%9.28M

213.87%12.96M

12.46%8.13M

-35.20%5.26M

-32.93%4.57M

-48.14%4.13M

17.71%7.23M

24.41%8.11M

59.99%6.81M

72.73%7.96M

-9.39%6.14M

11.54%6.52M

-20.12%4.26M

-20.74%4.61M

10.00%6.78M

-0.58%5.85M

6.75%5.33M

8.39%5.82M

-26.04%6.16M

-33.44%5.88M

-22.78%4.99M

29.24%5.37M

--8.33M

--8.84M

--6.46M

--4.15M

Non-current liabilities

Long-term debt and lease liabilities

152.62%141.16M

148.29%136.67M

6.46%57.73M

6.16%56.73M

6.06%55.88M

5.96%55.05M

5.85%54.23M

5.82%53.44M

5.79%52.69M

5.63%51.95M

2466.58%51.23M

2313.86%50.50M

12869.27%49.80M

11258.43%49.18M

321.10%2.00M

308.59%2.09M

-32.98%384.00K

-31.81%433.00K

-31.90%474.00K

-28.69%512.00K

334.09%573.00K

301.90%635.00K

278.26%696.00K

220.54%718.00K

116.39%132.00K

51.92%158.00K

--184.00K

--224.00K

--61.00K

--104.00K

-Long-term debt

155.20%140.97M

151.08%136.30M

7.20%57.19M

7.19%56.21M

7.19%55.24M

7.19%54.29M

7.19%53.35M

7.19%52.43M

7.19%51.53M

7.02%50.64M

--49.77M

--48.91M

--48.07M

--47.32M

----

-Long-term lease liabilities

-70.05%192.00K

-51.72%366.00K

-38.33%539.00K

-48.20%519.00K

-44.55%641.00K

-41.96%758.00K

-40.01%874.00K

-36.70%1.00M

-33.14%1.16M

-29.86%1.31M

-27.00%1.46M

-24.33%1.58M

350.26%1.73M

330.02%1.86M

321.10%2.00M

308.59%2.09M

-32.98%384.00K

-31.81%433.00K

-31.90%474.00K

-28.69%512.00K

334.09%573.00K

301.90%635.00K

278.26%696.00K

220.54%718.00K

116.39%132.00K

51.92%158.00K

--184.00K

--224.00K

--61.00K

--104.00K

Other non-current liabilities

--61.00K

--72.00K

--83.00K

--0.00

----

Total non-current liabilities

152.73%141.22M

148.42%136.74M

6.61%57.81M

6.16%56.73M

6.06%55.88M

5.96%55.05M

5.85%54.23M

5.82%53.44M

5.79%52.69M

5.63%51.95M

2466.58%51.23M

2313.86%50.50M

12869.27%49.80M

11258.43%49.18M

321.10%2.00M

308.59%2.09M

-32.98%384.00K

-31.81%433.00K

-31.90%474.00K

-28.69%512.00K

334.09%573.00K

301.90%635.00K

278.26%696.00K

220.54%718.00K

116.39%132.00K

51.92%158.00K

--184.00K

--224.00K

--61.00K

--104.00K

Total liabilities

150.77%163.41M

131.86%157.69M

15.14%71.79M

14.58%67.25M

13.81%65.16M

21.27%68.01M

6.67%62.35M

0.14%58.69M

1.14%57.25M

-1.86%56.08M

618.56%58.45M

580.43%58.61M

1120.06%56.61M

1033.15%57.15M

12.22%8.13M

35.46%8.61M

-21.37%4.64M

-21.83%5.04M

5.75%7.25M

-3.64%6.36M

15.19%5.90M

16.78%6.45M

-19.46%6.86M

-27.16%6.60M

-21.47%5.12M

29.79%5.52M

--8.51M

--9.06M

--6.52M

--4.26M

Shareholders' equity

Common equity

31.28%503.50M

28.92%492.72M

24.08%472.37M

14.37%433.69M

1.54%383.53M

1.56%382.18M

11.05%380.69M

11.23%379.19M

11.84%377.72M

12.25%376.30M

3.04%342.80M

3.21%340.92M

3.84%337.74M

3.88%335.23M

3.79%332.69M

3.72%330.32M

2.79%325.27M

4.23%322.72M

4.00%320.55M

23.14%318.49M

36.12%316.44M

33.97%309.61M

33.98%308.22M

12.61%258.63M

1.37%232.47M

4587.79%231.11M

--230.05M

--229.68M

--229.33M

--4.93M

Retained earnings

-20.94%-485.28M

-17.61%-456.67M

-17.16%-430.60M

-16.33%-413.19M

-16.06%-401.27M

-15.44%-388.31M

-12.73%-367.55M

-13.69%-355.18M

-16.28%-345.74M

-19.58%-336.38M

-22.41%-326.03M

-24.21%-312.42M

-25.47%-297.33M

-27.67%-281.29M

-29.09%-266.34M

-32.78%-251.53M

-35.25%-236.97M

-25.20%-220.33M

-26.22%-206.32M

-22.37%-189.44M

-22.68%-175.21M

-35.53%-175.98M

-44.02%-163.47M

-62.59%-154.80M

-73.37%-142.82M

-88.94%-129.84M

---113.50M

---95.21M

---82.38M

---68.72M

Capital reserves

24.41%118.52M

26.62%119.02M

29.26%119.75M

33.70%121.92M

6.10%95.26M

6.30%94.00M

12.58%92.64M

13.39%91.19M

15.75%89.79M

17.74%88.42M

39.98%82.29M

6.68%80.42M

6.22%77.57M

6.18%75.10M

-14.37%58.79M

12.98%75.38M

12.84%73.03M

22.17%70.73M

21.43%68.65M

109.32%66.72M

1016.86%64.72M

1123.89%57.89M

1385.86%56.54M

819.62%31.87M

85.98%5.79M

66.55%4.73M

--3.81M

--3.47M

--3.12M

--2.84M

Gains losses not affecting retained earnings

----

0.00%-1.63M

---1.63M

Total equity

202.67%18.22M

688.75%36.05M

217.71%41.77M

-14.62%20.50M

-155.49%-17.75M

-115.34%-6.12M

-21.61%13.15M

-15.76%24.01M

-20.86%31.98M

-25.98%39.92M

-74.72%16.77M

-63.06%28.50M

-53.37%40.41M

-46.47%53.94M

-41.08%66.35M

-39.45%77.16M

-37.92%86.66M

-23.67%100.76M

-21.32%112.60M

24.68%127.42M

58.60%139.59M

32.48%131.99M

24.54%143.12M

-23.06%102.20M

-39.43%88.02M

35.86%99.63M

--114.92M

--132.83M

--145.31M

--73.33M

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing MIST stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Milestone Pharmaceuticals Inc Have?



In its most recent quarterly, Milestone Pharmaceuticals Inc had 169.73M in cash and cash equivalents.

How Much Are Milestone Pharmaceuticals Inc's Total Liabilities?



Milestone Pharmaceuticals Inc reported 71.79M in total liabilities as of the latest reported quarter, including 13.98M in current liabilities and 57.81M in non-current liabilities.

What Are Milestone Pharmaceuticals Inc's Total Assets?



As of the latest reported quarter, Milestone Pharmaceuticals Inc's total assets were 113.56M, consisting of 111.92M in current assets and 1.64M in non-current assets.

How Much Shareholders' Equity Does Milestone Pharmaceuticals Inc Have?



Milestone Pharmaceuticals Inc reported 41.77M in total shareholders' equity as of the latest reported quarter.